Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Perrigo Company plc, 3 years.
Perrigo Company plc
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 2026 | Perrigo Company plc | Option exercise | +976 | $10.99 | $10,726 |
| Jun 12, 2026 | Perrigo Company plc | Shares withheld for tax | −469 | $10.99 | $5,154 |
| May 14, 2026 | Perrigo Company plc | Option exercise | +7,305 | $10.84 | $79,186 |
| May 14, 2026 | Perrigo Company plc | Shares withheld for tax | −3,507 | $10.84 | $38,016 |
| Feb 2, 2026 | Allogene Therapeutics Inc. | Open-market sale | −24,001 | $1.76 | $42,242 |
| Nov 12, 2025 | Perrigo Company plc | Open-market purchase | +7,500 | $14.18 | $106,350 |
| Oct 21, 2025 | Allogene Therapeutics Inc. | Open-market sale | −36,744 | $1.26 | $46,297 |
| Aug 18, 2025 | Perrigo Company plc | Open-market purchase | +4,375 | $22.97 | $100,494 |
| May 14, 2025 | Perrigo Company plc | Option exercise | +9,904 | $26.01 | $257,603 |
| May 14, 2025 | Perrigo Company plc | Shares withheld for tax | −4,754 | $26.01 | $123,652 |
| May 12, 2025 | Perrigo Company plc | Open-market purchase | +3,500 | $27.10 | $94,850 |
| Feb 3, 2025 | Allogene Therapeutics Inc. | Open-market sale | −4,361 | $1.73 | $7,545 |
| Jan 24, 2025 | Allogene Therapeutics Inc. | Grant or award | +173,913 | — | — |
| Oct 21, 2024 | Allogene Therapeutics Inc. | Shares withheld for tax | −36,404 | $2.84 | $103,387 |
| May 16, 2024 | Allogene Therapeutics Inc. | Grant or award | +344,828 | $2.90 | $1,000,001 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.